Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of Lightning on the Magnetic Properties of Volcanic Ash.
Genareau K, Hong YK, Lee W, Choi M, Rostaghi-Chalaki M, Gharghabi P, Gafford J, Klüss J. Genareau K, et al. Among authors: gafford j. Sci Rep. 2019 Mar 18;9(1):4726. doi: 10.1038/s41598-019-41265-3. Sci Rep. 2019. PMID: 30886229 Free PMC article.
The Elusive Evidence of Volcanic Lightning.
Genareau K, Gharghabi P, Gafford J, Mazzola M. Genareau K, et al. Among authors: gafford j. Sci Rep. 2017 Nov 14;7(1):15508. doi: 10.1038/s41598-017-15643-8. Sci Rep. 2017. PMID: 29138444 Free PMC article.
Refractive Error Change and Overminus Lens Therapy for Childhood Intermittent Exotropia.
Writing Committee for the Pediatric Eye Disease Investigator Group; Pediatric Eye Disease Investigator Group; Chen AM, Erzurum SA, Chandler DL, Hercinovic A, Wu R, Vricella M, Waters AL, Ticho BH, Erickson JW, Han S, McDowell PS, Li Z, Kraker RT, Holmes JM, Cotter SA. Writing Committee for the Pediatric Eye Disease Investigator Group, et al. JAMA Ophthalmol. 2024 Mar 21:e240276. doi: 10.1001/jamaophthalmol.2024.0276. Online ahead of print. JAMA Ophthalmol. 2024. PMID: 38536764
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
Mayer-Hamblett N, Ratjen F, Russell R, Donaldson SH, Riekert KA, Sawicki GS, Odem-Davis K, Young JK, Rosenbluth D, Taylor-Cousar JL, Goss CH, Retsch-Bogart G, Clancy JP, Genatossio A, O'Sullivan BP, Berlinski A, Millard SL, Omlor G, Wyatt CA, Moffett K, Nichols DP, Gifford AH; SIMPLIFY Study Group. Mayer-Hamblett N, et al. Lancet Respir Med. 2023 Apr;11(4):329-340. doi: 10.1016/S2213-2600(22)00434-9. Epub 2022 Nov 4. Lancet Respir Med. 2023. PMID: 36343646 Free PMC article. Clinical Trial.
31 results